Back to News
Market Impact: 0.6

Live updates: DOJ probes mortgage fraud claims against Federal Reserve governor, AP source says

FOXAFOXGOOGLGOOGAAPLMSFTPFEMRNANVAX
Elections & Domestic PoliticsLegal & LitigationHealthcare & BiotechRegulation & LegislationGeopolitics & WarSanctions & Export ControlsMonetary PolicyPandemic & Health Events
Live updates: DOJ probes mortgage fraud claims against Federal Reserve governor, AP source says

The Justice Department has opened a probe into mortgage fraud allegations against Federal Reserve Governor Lisa Cook, amid the Trump administration's efforts to remove her, while the President's Fed nominee, Stephen Miran, indicated he would maintain a White House role via unpaid leave if confirmed, raising significant concerns over the central bank's independence. Concurrently, the administration faces legal challenges for halting the Revolution Wind offshore project, highlighting regulatory uncertainty in renewable energy, and continues to assert executive power over independent agencies like the FTC, challenging their autonomy in the Supreme Court.

Analysis

Heightened political and regulatory uncertainty is creating significant headwinds across key sectors. The independence of the Federal Reserve is under direct threat, evidenced by a Department of Justice investigation into Governor Lisa Cook and Fed nominee Stephen Miran's stated intention to remain a White House employee if confirmed. This politicization of the central bank introduces unpredictable risk into monetary policy decisions. In the energy sector, the administration's halt of the nearly-completed Revolution Wind project injects substantial regulatory uncertainty for renewable energy investments, potentially delaying project timelines and deterring capital in the offshore wind industry. The healthcare and biotech sectors face a volatile policy landscape, highlighted by a contentious Senate hearing with Health Secretary Robert F. Kennedy Jr. Actions such as the FDA limiting access to updated COVID-19 shots, the reported cancellation of $500 million in mRNA-platform contracts, and Kennedy's public questioning of vaccine efficacy create a challenging operating environment for manufacturers like Pfizer, Moderna, and Novavax. This trend of executive intervention is further underscored by legal efforts to remove a Federal Trade Commission commissioner, signaling a broader pattern of challenging the autonomy of independent agencies.